Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$379M |
| 2 |
Starbucks
SBUX
|
+$371M |
| 3 |
APC
Anadarko Petroleum
APC
|
+$287M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$263M |
| 5 |
Tesla
TSLA
|
+$253M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fortive
FTV
|
+$1.27B |
| 2 |
ANDV
Andeavor
ANDV
|
+$1.11B |
| 3 |
AET
Aetna Inc
AET
|
+$535M |
| 4 |
Microsoft
MSFT
|
+$350M |
| 5 |
Amazon
AMZN
|
+$290M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 13.69% |
| 2 | Technology | 13.64% |
| 3 | Financials | 12.49% |
| 4 | Consumer Discretionary | 10.83% |
| 5 | Industrials | 9.5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
676
CALL
iShares Biotechnology ETF
IBB
$10.7B
| $21.8M | 0.03% |
226,300
+85,700
| +61% | +$9.1M |
|
677
Cintas
CTAS
$83B
| $21.7M | 0.03% |
517,408
+449,124
| +658% | +$20.1M |
|
|
ARCH
678
DELISTED
Arch Resources, Inc.
ARCH
| $21.7M | 0.03% |
261,492
+84,108
| +47% | +$7.48M |
|
679
Enovis
ENOV
$1.45B
| $21.7M | 0.03% |
602,395
+557,416
| +1,239% | +$26M |
|
680
SPDR Gold Trust
GLD
$155B
| $21.7M | 0.03% |
178,670
+71,553
| +67% | +$8.31M |
|
681
Match Group
MTCH
$9.58B
| $21.6M | 0.03% |
505,407
-345,407
| -41% | -$15.9M |
|
|
FLIR
682
DELISTED
FLIR Systems, Inc. (DE) Common Stock
FLIR
| $21.6M | 0.03% |
496,309
+129,795
| +35% | +$6.38M |
|
|
TVTY
683
DELISTED
Tivity Health, Inc. Common Stock
TVTY
| $21.5M | 0.03% |
867,656
+626,096
| +259% | +$20.8M |
|
684
Sabre
SABR
$912M
| $21.5M | 0.03% |
992,120
-1,271,043
| -56% | -$30.8M |
|
685
Eagle Materials
EXP
$6.27B
| $21.4M | 0.03% |
351,448
-490,181
| -58% | -$35.1M |
|
686
Penumbra
PEN
$12.8B
| $21.3M | 0.03% |
174,673
+47,589
| +37% | +$6.37M |
|
687
American Eagle Outfitters
AEO
$2.83B
| $21.3M | 0.03% |
1,103,180
+1,003,501
| +1,007% | +$20.9M |
|
688
Ares Capital
ARCC
$14.4B
| $21.2M | 0.03% |
1,362,669
+358,323
| +36% | +$5.93M |
|
689
Knight Transportation
KNX
$11.2B
| $21.2M | 0.03% |
846,798
+432,395
| +104% | +$13.4M |
|
|
BRSL
690
Brightstar Lottery PLC
BRSL
$2.16B
| $21.1M | 0.03% |
1,445,244
-5,069,281
| -78% | -$83.8M |
|
691
Medifast
MED
$134M
| $21.1M | 0.03% |
169,091
+95,242
| +129% | +$16.3M |
|
692
CALL
VanEck Gold Miners ETF
GDX
$32.2B
| $21.1M | 0.03% |
1,000,000
+850,000
| +567% | +$16.7M |
|
|
VRAY
693
DELISTED
ViewRay, Inc.
VRAY
| $21.1M | 0.03% |
3,472,483
-359,642
| -9% | -$2.69M |
|
|
IMGN
694
DELISTED
Immunogen Inc
IMGN
| $21.1M | 0.03% |
4,389,260
+3,552,118
| +424% | +$21.6M |
|
695
Post Holdings
POST
$3.73B
| $21.1M | 0.03% |
360,990
-552,395
| -60% | -$33.3M |
|
696
Watsco Inc
WSO
$12.8B
| $21M | 0.03% |
151,099
+42,701
| +39% | +$6.51M |
|
697
Americold
COLD
$4.31B
| $21M | 0.03% |
821,357
-663,558
| -45% | -$17M |
|
698
American Express
AXP
$228B
| $20.9M | 0.03% |
219,400
-477,696
| -69% | -$50M |
|
|
SHPG
699
CALL
DELISTED
Shire pic
SHPG
| $20.9M | 0.03% |
120,000
-370,000
| -76% | -$64.7M |
|
700
Atmos Energy
ATO
$28.4B
| $20.9M | 0.03% |
225,178
+112,906
| +101% | +$10.8M |
|
Similar funds
Israel Englander's Q4 2018 Portfolio in Review
As of Q4 2018, Israel Englander held 4,541 positions worth $64.1B, down 21% from $81.6B the previous quarter. Its ten largest holdings account for 6.7% of the portfolio.
Israel Englander withdrew a net $4.25B in Q4 2018, closing 844 positions and reducing 1,571 holdings. Its most notable exit was Andeavor, an estimated $1.11B position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 14% of assets, up from 12% a quarter earlier, followed by Technology and Financials.
Against the trend, Israel Englander opened a new position in Athenahealth, Inc. worth $135M.
- Israel Englander's largest Q4 2018 buy was Athenahealth, Inc.: 1,022,505 shares worth $135M.
- Israel Englander added most to Celgene Corp in Q4 2018, an estimated $379M increase.
- Israel Englander's biggest Q4 2018 reduction was Fortive, cutting an estimated $1.27B.
- Israel Englander fully exited Andeavor in Q4 2018, selling an estimated $1.11B.
- Israel Englander's ten largest holdings make up 6.7% of its $64.1B portfolio in Q4 2018.
- Israel Englander opened 702 new positions and closed 844 in Q4 2018.
- Israel Englander's portfolio value fell 21% quarter-over-quarter to $64.1B.
Based on Millennium Management's 13F filing for Q4 2018, filed 14 Feb 2019.